Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
"Clinical and preclinical exploration of gene and cellular immunotherapy have seen rapid growth and interest with the development and approval of five Chimeric Antigen Receptor T-cell (CAR-T) products for lymphoma and myeloma and one Bispecific T-Cell Engager (BiTE) for acute lymphoblastic leukemia…
c.1 BC Cancer Agency VIC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency ARHCC Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency SUR Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VAN Cancer Info Ctr | Available | ||
c.2 BC Cancer Agency PG Cancer Info Ctr | Available | ||
c.1 BC Cancer Agency PG Cancer Info Ctr Missing | Available |
Content:; Melanoma / Ali Al-Haseni and Debjani Sahni -- Squamous cell carcinoma / Ali Al-Haseni and Debjani Sahni -- Basal cell carcinoma / Ali Al-Haseni and Debjani Sahni -- Cutaneous lymphoma / Bilal Fawaz and Debjani Sahni -- Kaposi's sarcoma / Bilal Fawaz and Debjani Sahni -- Dermatofibrosarcom…
"With cancer ranking as the primary or secondary cause of premature death in almost 100 countries worldwide, the World Health Organization recognized a high level of investment in cancer control and treatment (including palliative care) in 2019. At that time, governments at the World Health Assembl…